相关实验视频
Updated: Jan 14, 2026

10:43
Evaluating In Vitro DNA Damage Using Comet Assay
Published on: October 11, 2017
39.4K
NR2F6通过E2F2-PARP1通路调节结质瘤中的Temozolomide耐药性
Bo Wang1, Pengfei Xue2, Rongrong Li1
1Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng, 252000, Shandong Province, P.R. China.
Cancer cell international
|October 22, 2025
概括
核受体NR2F6通过上调E2F2和PARP1.1来促进质瘤中temozolomide (TMZ) 的耐药性. 这种机制增强了DNA修复,降低了治疗的有效性,并影响了高度质瘤患者的预后.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 质瘤是一种常见的成年大脑瘤,标准治疗方法是temozolomide (TMZ).
- 对TMZ的耐药性是恶性质瘤治疗的一个主要挑战.
- 了解TMZ抵抗机制对于改善患者的治疗结果至关重要.
研究的目的:
- 为了阐明NR2F6在质瘤中特莫索洛米德 (TMZ) 耐药性的作用.
- 调查NR2F6介导的TMZ耐药性背后的分子机制.
主要方法:
- 来自TCGA和CGGA质瘤队伍的RNA测序数据的分析.
- 在内部质瘤患者队列中验证NR2F6表达.
- 在体外构建TMZ抗性质瘤细胞系以研究NR2F6功能.
主要成果:
- 高度质瘤中NR2F6表达显著上调,与预后不佳相关.
- 在TMZ抗性细胞中,NR2F6被上调,从而诱导质瘤细胞的抗性.
- E2F2-PARP1轴介导NR2F6在TMZ抵抗中的作用.
结论:
- 核转录因子NR2F6对E2F2转录进行上调.
- 增加E2F2表达导致增强PARP1表达.
- 这一途径促进TMZ诱导的DNA损伤修复,降低质瘤对TMZ的敏感性.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The Retinoblastoma Gene
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K

